Monika Schmelz

  • 1635 Citations
  • 19 h-Index
1986 …2017
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 2 Similar Profiles
Desmogleins Medicine & Life Sciences
Desmosomes Medicine & Life Sciences
Cadherins Medicine & Life Sciences
Desmoplakins Medicine & Life Sciences
Histocompatibility Antigens Class II Medicine & Life Sciences
Glycoproteins Medicine & Life Sciences
Epithelial Cells Medicine & Life Sciences
Vinculin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1986 2017

  • 1635 Citations
  • 19 h-Index
  • 33 Article
  • 1 Conference contribution
3 Citations

Aberrant cytoplasmic expression of MHCII confers worse progression free survival in diffuse large B-cell lymphoma

Kendrick, S., Rimsza, L. M., Scott, D. W., Slack, G. W., Farinha, P., Tan, K. L., Persky, D., Puvvada, S., Connors, J. M., Sehn, L., Gascoyne, R. D. & Schmelz, M. Jan 1 2017 In : Virchows Archiv. 470, 1, p. 113-117 5 p.

Research output: Contribution to journalArticle

1 Citations

A Phase II Exploratory Study of PXD-101 (Belinostat) Followed by Zevalin in Patients with Relapsed Aggressive High-Risk Lymphoma

Puvvada, S. D., Guillén-Rodríguez, J. M., Rivera, X. I., Heard, K., Inclan, L., Schmelz, M., Schatz, J. H. & Persky, D. O. Sep 5 2017 (Accepted/In press) In : Oncology (Switzerland).

Research output: Contribution to journalArticle

Lymphoma
Lymphoma, Large B-Cell, Diffuse
Major Histocompatibility Complex
Biomarkers
Histone Deacetylases

Come in Out of the Cold: Alternatives to Freezing for Microbial Biorepositories

Isaacs, E. & Schmelz, M. Feb 15 2017 In : Clinical Microbiology Newsletter. 39, 4, p. 27-34 8 p.

Research output: Contribution to journalArticle

Nucleic Acids
Freezing
Technology
Costs and Cost Analysis
Quality Control
10 Citations

A phase II study of belinostat (PXD101) in relapsed and refractory aggressive B-cell lymphomas: SWOG S0520

Puvvada, S. D., Li, H., Rimsza, L. M., Bernstein, S. H., Fisher, R. I., LeBlanc, M., Schmelz, M., Glinsmann-Gibson, B., Miller, T. P., Maddox, A. M., Friedberg, J. W., Smith, S. M. & Persky, D. O. Jan 12 2016 (Accepted/In press) In : Leukemia and Lymphoma. p. 1-11 11 p.

Research output: Contribution to journalArticle

Histocompatibility Antigens Class II
B-Cell Lymphoma
Tumor-Infiltrating Lymphocytes
T-Lymphocytes
Tumor Microenvironment
2 Citations

Belinostat and vincristine demonstrate mutually synergistic cytotoxicity associated with mitotic arrest and inhibition of polyploidy in a preclinical model of aggressive diffuse large B cell lymphoma

Havas, A. P., Rodrigues, K. B., Bhakta, A., Demirjian, J. A., Hahn, S., Tran, J., Scavello, M., Tula-Sanchez, A. A., Zeng, Y., Schmelz, M. & Smith, C. L. Dec 1 2016 In : Cancer Biology and Therapy. 17, 12, p. 1240-1252 13 p.

Research output: Contribution to journalArticle

Histone Deacetylase Inhibitors
Polyploidy
Lymphoma, Large B-Cell, Diffuse
Vincristine
Cell Line